161 related articles for article (PubMed ID: 37849539)
1. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
[TBL] [Abstract][Full Text] [Related]
2. Novel Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
[TBL] [Abstract][Full Text] [Related]
3. Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1045-1046. PubMed ID: 37583830
[TBL] [Abstract][Full Text] [Related]
4. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
[TBL] [Abstract][Full Text] [Related]
5. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
[TBL] [Abstract][Full Text] [Related]
6. Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):775-776. PubMed ID: 38894910
[TBL] [Abstract][Full Text] [Related]
7. Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):748-749. PubMed ID: 38894901
[TBL] [Abstract][Full Text] [Related]
8. Imidazopyridine Compounds as ERK5 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Jun; 15(6):777-778. PubMed ID: 38894904
[TBL] [Abstract][Full Text] [Related]
9. Novel Phosphorylpurinone Compounds for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):441-442. PubMed ID: 38628787
[TBL] [Abstract][Full Text] [Related]
10. Novel PARP7 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1615-1616. PubMed ID: 38116422
[TBL] [Abstract][Full Text] [Related]
11. Novel PARP1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1629-1630. PubMed ID: 38116419
[TBL] [Abstract][Full Text] [Related]
12. Novel PARP1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):161-162. PubMed ID: 38352834
[TBL] [Abstract][Full Text] [Related]
13. Novel CD73 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):571-572. PubMed ID: 38746902
[TBL] [Abstract][Full Text] [Related]
14. Novel IL4I1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jun; 14(6):700-701. PubMed ID: 37312856
[TBL] [Abstract][Full Text] [Related]
15. Novel Lactams as CBL-B Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):897-898. PubMed ID: 37465298
[TBL] [Abstract][Full Text] [Related]
16. Novel Diaminopyrimidine Carboxamides as HPK1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):899-900. PubMed ID: 37465291
[TBL] [Abstract][Full Text] [Related]
17. Novel Lactams as Cbl-b Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2022 Oct; 13(10):1556-1557. PubMed ID: 36267136
[TBL] [Abstract][Full Text] [Related]
18. Boron-Containing Pyrazole Compounds as JAK Inhibitors for Treating Inflammation, Autoimmune Diseases, and Cancer.
Sabnis RW
ACS Med Chem Lett; 2022 Oct; 13(10):1554-1555. PubMed ID: 36267133
[TBL] [Abstract][Full Text] [Related]
19. Novel Exatecan-Derived Topoisomerase-1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):579-580. PubMed ID: 38746899
[TBL] [Abstract][Full Text] [Related]
20. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1336-1337. PubMed ID: 37849559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]